Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 862

1.

Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.

Faggioni M, Baber U, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Claessen BE, Dangas GD, Gibson CM, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Farhan S, Ariti C, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007133. doi: 10.1161/CIRCINTERVENTIONS.118.007133.

PMID:
30998384
2.

Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53.

Zelniker TA, Morrow DA, Mosenzon O, Gurmu Y, Im K, Cahn A, Raz I, Steg PG, Leiter LA, Braunwald E, Bhatt DL, Scirica BM.

Clin Chem. 2019 Apr 15. pii: clinchem.2018.298489. doi: 10.1373/clinchem.2018.298489. [Epub ahead of print]

PMID:
30988169
3.

Management strategies and 5-year outcomes in Polish patients with stable coronary artery disease in the CLARIFY registry versus other European countries.

Parma Z, Young R, Roleder T, Marona M, Ford I, Tendera M, Steg PG, Stępińska J.

Pol Arch Intern Med. 2019 Apr 5. doi: 10.20452/pamw.14789. [Epub ahead of print]

4.

Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial.

Lip GYH, Mauri L, Montalescot G, Ozkor M, Vardas P, Steg PG, Bhatt DL, Hohnloser SH, Miede C, Nordaby M, Brueckmann M, Kreuzer J, Kimura T, Oldgren J, Ten Berg JM, Cannon CP.

Am Heart J. 2019 Mar 1;212:13-22. doi: 10.1016/j.ahj.2019.02.006. [Epub ahead of print]

PMID:
30928824
5.

Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial.

Jukema JW, Szarek M, Zijlstra LE, de Silva HA, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Karpov Y, Moryusef A, Pordy R, Prieto JC, Roe MT, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

J Am Coll Cardiol. 2019 Mar 12. pii: S0735-1097(19)33921-X. doi: 10.1016/j.jacc.2019.03.013. [Epub ahead of print]

PMID:
30898609
6.

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Gregson J, Pocock SJ, Ballantyne CM; REDUCE-IT Investigators.

J Am Coll Cardiol. 2019 Mar 18. pii: S0735-1097(19)33796-9. doi: 10.1016/j.jacc.2019.02.032. [Epub ahead of print]

7.

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial.

Serruys PW, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang CC, Spitzer E, Walsh SJ, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen JGP, Rademaker-Havinga T, Garg S, Steg PG, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt FWA.

EuroIntervention. 2019 Mar 19. pii: EIJ-D-19-00202. doi: 10.4244/EIJ-D-19-00202. [Epub ahead of print]

8.

Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y12 Inhibitor Pretreatment.

Abtan J, Ducrocq G, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, White HD, Harrington RA, Bhatt DL.

Circ Cardiovasc Interv. 2019 Mar;12(3):e007445. doi: 10.1161/CIRCINTERVENTIONS.118.007445.

PMID:
30871355
9.

Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation.

Palmerini T, Bruno AG, Gilard M, Morice MC, Valgimigli M, Montalescot G, Collet JP, Della Riva D, Bacchi-Reggiani ML, Steg PG, Diallo A, Vicaut E, Helft G, Nakamura M, Généreux P, Vahl TP, Stone GW.

Circ Cardiovasc Interv. 2019 Mar;12(3):e007541. doi: 10.1161/CIRCINTERVENTIONS.118.007541.

PMID:
30871353
10.

Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular Events.

Abboud H, Monteiro Tavares L, Labreuche J, Arauz A, Bryer A, Lavados PM, Massaro A, Munoz Collazos M, Steg PG, Yamout BI, Vicaut E, Amarenco P.

Stroke. 2019 Apr;50(4):853-858. doi: 10.1161/STROKEAHA.118.022180.

PMID:
30852970
11.

Pre-treatment with a P2Y12 antagonist before PCI in STEMI: why should we wait?

Abtan J, Steg PG.

Eur Heart J. 2019 Apr 14;40(15):1211-1213. doi: 10.1093/eurheartj/ehz058. No abstract available.

PMID:
30851044
12.

Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study.

Chichareon P, Modolo R, van Klaveren D, Takahashi K, Kogame N, Chang CC, Katagiri Y, Tomaniak M, Asano T, Spitzer E, Buszman P, Prokopczuk J, Fath-Ordoubadi F, Buysschaert I, Anderson R, Oldroyd KG, Merkely B, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Onuma Y, Serruys PW.

Int J Cardiol. 2019 Feb 20. pii: S0167-5273(18)36315-0. doi: 10.1016/j.ijcard.2019.02.043. [Epub ahead of print]

PMID:
30846254
13.

Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease.

Picard F, Bhatt DL, Ducrocq G, Elbez Y, Ferrari R, Ford I, Tardif JC, Tendera M, Fox KM, Steg PG.

J Am Coll Cardiol. 2019 Mar 26;73(11):1362-1364. doi: 10.1016/j.jacc.2019.01.016. Epub 2019 Feb 25. No abstract available.

PMID:
30819552
14.

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.

Oldgren J, Steg PG, Hohnloser SH, Lip GYH, Kimura T, Nordaby M, Brueckmann M, Kleine E, Ten Berg JM, Bhatt DL, Cannon CP.

Eur Heart J. 2019 Feb 21. pii: ehz059. doi: 10.1093/eurheartj/ehz059. [Epub ahead of print]

PMID:
30793734
15.

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.

Bhatt DL, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Andersson M, Himmelmann A, Ridderstråle W, Held C, Steg PG; THEMIS Steering Committee.

Clin Cardiol. 2019 Feb 20. doi: 10.1002/clc.23164. [Epub ahead of print]

16.

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.

Costa F, Van Klaveren D, Feres F, James S, Räber L, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators.

J Am Coll Cardiol. 2019 Feb 26;73(7):741-754. doi: 10.1016/j.jacc.2018.11.048.

PMID:
30784667
17.

Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study.

Bezin J, Moore N, Mansiaux Y, Steg PG, Pariente A.

Am J Med. 2019 Jan 18. pii: S0002-9343(19)30062-2. doi: 10.1016/j.amjmed.2018.12.032. [Epub ahead of print]

PMID:
30660573
18.

The DAPT Score in Sweden: Successful Validation, Flawed Interpretation.

Yeh RW, Kereiakes DJ, Secemsky EA, Steg PG, Mauri L.

J Am Coll Cardiol. 2019 Jan 8;73(1):113-114. doi: 10.1016/j.jacc.2018.10.053. No abstract available.

PMID:
30621941
19.

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.

Baber U, Leisman DE, Cohen DJ, Gibson CM, Henry TD, Dangas G, Moliterno D, Kini A, Krucoff M, Colombo A, Chieffo A, Sartori S, Witzenbichler B, Steg PG, Pocock SJ, Mehran R.

Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004945. doi: 10.1161/CIRCOUTCOMES.118.004945.

PMID:
30606052
20.

β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study.

Sorbets E, Steg PG, Young R, Danchin N, Greenlaw N, Ford I, Tendera M, Ferrari R, Merkely B, Parkhomenko A, Reid C, Tardif JC, Fox KM.

Eur Heart J. 2018 Dec 27. doi: 10.1093/eurheartj/ehy811. [Epub ahead of print]

PMID:
30590529

Supplemental Content

Loading ...
Support Center